Madrigal Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MADRIGAL
MADRIGAL has one approved drug.
There are eight US patents protecting MADRIGAL drugs.
Summary for Madrigal
| US Patents: | 8 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Madrigal
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Madrigal | REZDIFFRA | resmetirom | TABLET;ORAL | 217785-001 | Mar 14, 2024 | RX | Yes | No | 11,564,926 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Madrigal | REZDIFFRA | resmetirom | TABLET;ORAL | 217785-001 | Mar 14, 2024 | RX | Yes | No | 9,266,861 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Madrigal | REZDIFFRA | resmetirom | TABLET;ORAL | 217785-002 | Mar 14, 2024 | RX | Yes | No | 10,376,517 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Madrigal | REZDIFFRA | resmetirom | TABLET;ORAL | 217785-002 | Mar 14, 2024 | RX | Yes | No | 12,377,104 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Madrigal | REZDIFFRA | resmetirom | TABLET;ORAL | 217785-001 | Mar 14, 2024 | RX | Yes | No | 7,452,882 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Madrigal | REZDIFFRA | resmetirom | TABLET;ORAL | 217785-003 | Mar 14, 2024 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Madrigal Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| New Zealand | 746295 | ⤷ Start Trial |
| Singapore | 11201501907Y | ⤷ Start Trial |
| Malaysia | 170520 | ⤷ Start Trial |
| New Zealand | 746298 | ⤷ Start Trial |
| Russian Federation | 2015114327 | ⤷ Start Trial |
| Argentina | 132930 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Madrigal Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 4406594 | 301369 | Netherlands | ⤷ Start Trial | PRODUCT NAME: RESMETIROM OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/25/1962 20250819 |
| 4406594 | 202640005 | Slovenia | ⤷ Start Trial | PRODUCT NAME: RESMETIROM OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; NATIONAL AUTHORISATION NUMBER: EU/1/25/1962; DATE OF NATIONAL AUTHORISATION: 20250818; AUTHORITY FOR NATIONAL AUTHORISATION: EU |
| 4406594 | LUC50038 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: RESMETIROM OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; AUTHORISATION NUMBER AND DATE: EU/1/25/1962 20250819 |
| 4406594 | CA 2026 00008 | Denmark | ⤷ Start Trial | PRODUCT NAME: RESMETIROM ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/25/1962 20250819 |
| 4406594 | 2026C/705 | Belgium | ⤷ Start Trial | PRODUCT NAME: RESMETIROM OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; AUTHORISATION NUMBER AND DATE: EU/1/25/1962 20250819 |
| 4406594 | C20265007 | Finland | ⤷ Start Trial | |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
